X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PFIZER - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PFIZER BIOCON /
PFIZER
 
P/E (TTM) x 41.3 33.6 122.9% View Chart
P/BV x 7.2 5.3 135.1% View Chart
Dividend Yield % 0.2 0.6 25.1%  

Financials

 BIOCON    PFIZER
EQUITY SHARE DATA
    BIOCON
Mar-18
PFIZER
Mar-18
BIOCON /
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,1882,365 50.2%   
Low Rs3051,625 18.8%   
Sales per share (Unadj.) Rs68.7430.3 16.0%  
Earnings per share (Unadj.) Rs7.678.7 9.6%  
Cash flow per share (Unadj.) Rs14.093.2 15.0%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %0.11.0 13.4%  
Book value per share (Unadj.) Rs86.3586.5 14.7%  
Shares outstanding (eoy) m600.0045.75 1,311.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.94.6 234.3%   
Avg P/E ratio x98.925.3 390.0%  
P/CF ratio (eoy) x53.421.4 249.6%  
Price / Book Value ratio x8.63.4 254.2%  
Dividend payout %13.225.4 52.1%   
Avg Mkt Cap Rs m447,90091,271 490.7%   
No. of employees `0006.12.6 233.8%   
Total wages/salary Rs m9,3113,143 296.3%   
Avg. sales/employee Rs Th6,705.87,484.8 89.6%   
Avg. wages/employee Rs Th1,514.21,195.0 126.7%   
Avg. net profit/employee Rs Th736.91,369.1 53.8%   
INCOME DATA
Net Sales Rs m41,23419,685 209.5%  
Other income Rs m2,0621,143 180.4%   
Total revenues Rs m43,29620,828 207.9%   
Gross profit Rs m8,2915,003 165.7%  
Depreciation Rs m3,851663 581.3%   
Interest Rs m6154 14,642.9%   
Profit before tax Rs m5,8875,479 107.4%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5691,878 83.5%   
Profit after tax Rs m4,5313,601 125.8%  
Gross profit margin %20.125.4 79.1%  
Effective tax rate %26.734.3 77.7%   
Net profit margin %11.018.3 60.1%  
BALANCE SHEET DATA
Current assets Rs m41,48624,167 171.7%   
Current liabilities Rs m21,4139,544 224.4%   
Net working cap to sales %48.774.3 65.5%  
Current ratio x1.92.5 76.5%  
Inventory Days Days6455 116.1%  
Debtors Days Days9429 328.1%  
Net fixed assets Rs m50,6619,514 532.5%   
Share capital Rs m3,000458 655.7%   
"Free" reserves Rs m48,80826,375 185.1%   
Net worth Rs m51,80826,832 193.1%   
Long term debt Rs m17,89825 71,592.0%   
Total assets Rs m99,89736,900 270.7%  
Interest coverage x10.61,305.5 0.8%   
Debt to equity ratio x0.30 37,078.4%  
Sales to assets ratio x0.40.5 77.4%   
Return on assets %5.29.8 52.7%  
Return on equity %8.713.4 65.2%  
Return on capital %9.620.4 47.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05822 53,830.4%   
Fx outflow Rs m7,3481,489 493.6%   
Net fx Rs m4,710-1,466 -321.2%   
CASH FLOW
From Operations Rs m6,6213,318 199.5%  
From Investments Rs m-6,840-2,383 287.0%  
From Financial Activity Rs m-2,397-1,104 217.2%  
Net Cashflow Rs m-2,612-169 1,550.1%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.6 63.9 32.2%  
Indian inst/Mut Fund % 8.4 7.5 112.0%  
FIIs % 10.7 4.9 218.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 23.7 84.0%  
Shareholders   109,995 85,207 129.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  DISHMAN PHARMA  FULFORD INDIA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 324 Points Lower; Metal and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 25, 2019 (Close)

TRACK BIOCON

BIOCON - CIPLA COMPARISON

COMPARE BIOCON WITH

MARKET STATS